## Abstract Hepatocellular carcinoma (HCC) is one of the deadliest forms of human liver cancer and does not respond well to conventional therapies. Novel effective treatments are urgently in need. G‐protein‐coupled kinase 2 (GRK2) is unique serine/threonine kinase that involves in many signaling pa
Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein α1
✍ Scribed by He-Xin Yan; Hong-Yang Wang; Rui Zhang; Lei Chen; Bao-An Li; Shu-Qin Liu; Hui-Fang Cao; Xiu-Hua Qiu; Yun-Feng Shan; Zhong-Hua Yan; Hong-Ping Wu; Ye-Xiong Tan; Meng-Chao Wu
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 571 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Signal regulatory protein (SIRP) ␣1 is a member of the SIRP family that undergoes tyrosine phosphorylation and binds SHP-2 tyrosine phosphatase in response to various mitogens. The expression levels of SIRP␣1 were decreased in HCC tissues, compared with the matched normal tissues. Exogenous expression of wild type SIRP␣1, but not of a mutant SIRP␣1 lacking the tyrosine phosphorylation sites, in SIRP␣1-negative Huh7 human HCC cells resulted in suppression of tumor cell growth both in vitro and in vivo. Treatment of Huh7 transfectants with EGF or HGF induced tyrosine phosphorylation of SIRP␣1 and its association with SHP-2, which were accompanied by reduced ERK1 activation. Expression of SIRP␣1 significantly suppressed activation of NF-B and also sensitized Huh7 cells to TNF␣ or cisplatin-induced cell death. In addition, SIRP␣1-transfected Huh7 cells displayed reduced cell migration and cell spreading in a fashion that was dependent on SIRP␣1/SHP-2 complex formation. In conclusion, a negative regulatory effect of SIRP␣1 on hepatocarcinogenesis is exerted, at least in part, through inhibition of ERK and NF-B pathways.
📜 SIMILAR VOLUMES
The normal myeloid hematopoietic regulatory proteins include one class of proteins that induces viability and multiplication of normal myeloid precursor cells to form colonies (called MGI-I = CSF or 11-3) and another class (called MGI-2
CD5, a membrane-associated glycoprotein, has been shown to negatively regulate antigen receptor-mediated growth responses in peritoneal B lymphocytes, thymocytes and mature T cells. The CD5-expressing peritoneal B cells (B-1) that are normally unresponsive to B cell receptor (BCR)-mediated growth si
## Abstract The activation of signal transducers and activators of transcription 3 (STAT3) has been closely linked with the proliferation, survival, invasion, and angiogenesis of hepatocellular carcinoma (HCC) and represents an attractive target for therapy. In the present report, we investigated w
## Abstract All‐trans retinoic acid (ATRA), a synthetic derivative of vitamin A, inhibits the growth of breast cancer cells. To elucidate the mechanism by which ATRA causes cell growth inhibition, we examined changes in cell cycle and intracellular signaling pathways, focusing on protein kinase C (